Shaping the Gastrointestinal Stromal Tumor Market in 2025: Increasing Focus On Drug Approvals To Drive The Revenues

How Big Is the Gastrointestinal Stromal Tumor Market Expected to Be, and What Will Its Growth Rate Be?
The gastrointestinal stromal tumor (GIST) market will grow from $1.28 billion in 2024 to $1.37 billion in 2025, at a CAGR of 7.2%. The growth is driven by increased awareness, early diagnosis, the emergence of targeted therapies, improved surgical techniques, personalized medicine development, and advancements in supportive care.

The gastrointestinal stromal tumor market is expected to reach $1.82 billion by 2029, growing at a CAGR of 7.4%. Research advancements, precision medicine, and expanding access to targeted therapies are driving factors. Trends in this market include collaboration in research, diagnostic advancements, and early detection efforts.

What Are the Primary Growth Drivers for the Gastrointestinal Stromal Tumor Market?
The increasing incidence of stomach cancer is expected to propel the growth of the gastrointestinal stromal tumor (GIST) market. Stomach cancer involves the uncontrolled growth of malignant cells in the stomach lining, while GISTs can occur in the stomach. The American Cancer Society estimated that 26,890 new cases of stomach cancer and 10,880 deaths would occur in the U.S. in 2024. Therefore, the rising incidence of stomach cancer is driving the growth of the GIST market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13248&type=smp

Who Are the Dominant Companies Influencing Gastrointestinal Stromal Tumor Market Trends?
Major companies operating in the gastrointestinal stromal tumor market report are Pfizer Inc., F. Hoffmann-La Roche AG, Bayer AG, Novartis AG, Merck & Co. Inc., GlaxoSmithKline PLC, Bristol-Myers Squibb Company, Sanofi S.A., AstraZeneca PLC, Eli Lilly and Company, Daiichi Sankyo Co. Ltd., Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Jiangsu Hengrui Medicine Co. Ltd., Exelixis Inc., NATCO Pharma Ltd., Blueprint Medicines Corporation, Array BioPharma Inc., Deciphera Pharmaceuticals Inc., Ono Pharmaceutical Co. Ltd., Boston Biomedical Inc., DNAtrix Inc., Advenchen Laboratories LLC, Arog Pharmaceuticals Inc., AB Sciences S.A.

How Is the Gastrointestinal Stromal Tumor Market Evolving?
In the gastrointestinal stromal tumor market, companies are developing new treatments like QINLOCK (Ripretinib) to reach a broader customer base and increase sales. QINLOCK is a drug for advanced gastrointestinal stromal tumors. For example, in January 2024, the US Food and Drug Administration (FDA) reported a rise in novel drug approvals, with 37 in 2022 and 55 in 2023, 20 of which were first-in-class drugs.

What Are the Different Segmentations in the Gastrointestinal Stromal Tumor Market?
The gastrointestinal stromal tumor market covered in this report is segmented -

1) By Treatment Type: Chemotherapy, Targeted Therapy, Other Treatment Types
2) By Indication: Stomach, Small Intestine, Others Indications
3) By End-User: Hospitals, Clinics, Specialized Cancer Treatment Centers, Other End-Users

Subsegments:
1) By Chemotherapy: Traditional Chemotherapy Agents, Combination Chemotherapy Regimens
2) By Targeted Therapy: Tyrosine Kinase Inhibitors, Other Targeted Agents
3) By Other Treatment Types: Surgery, Radiation Therapy, Clinical Trials For Novel Therapies

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/gastrointestinal-stromal-tumor-global-market-report

Which Region Is at the Forefront of the Gastrointestinal Stromal Tumor Market?
North America was the largest region in the gastrointestinal stromal tumor market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal stromal tumor market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Is Covered In The Gastrointestinal Stromal Tumor Global Market Report?

- Market Size Analysis: Analyze the Gastrointestinal Stromal Tumor Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Gastrointestinal Stromal Tumor Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Gastrointestinal Stromal Tumor Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Gastrointestinal Stromal Tumor Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13248

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.